Susquehanna International Group’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
8,100
+4,100
+103% +$790K ﹤0.01% 6840
2025
Q4
$757K Buy
4,000
+2,600
+186% +$481K ﹤0.01% 7843
2025
Q3
$232K Sell
1,400
-400
-22% -$65.2K ﹤0.01% 10667
2025
Q2
$276K Sell
1,800
-11,800
-87% -$1.76M ﹤0.01% 10542
2025
Q1
$2.14M Buy
+13,600
New +$2.21M ﹤0.01% 5376
2024
Q4
Sell
-12,500
Closed -$2.22M 12170
2024
Q3
$2.22M Buy
12,500
+6,800
+119% +$1.21M ﹤0.01% 5065
2024
Q2
$960K Buy
+5,700
New +$932K ﹤0.01% 6697
2023
Q3
Sell
-2,400
Closed -$375K 12004
2023
Q2
$375K Buy
2,400
+600
+33% +$95.9K ﹤0.01% 8986
2023
Q1
$292K Sell
1,800
-900
-33% -$146K ﹤0.01% 9786
2022
Q4
$431K Buy
2,700
+1,000
+59% +$158K ﹤0.01% 8251
2022
Q3
$239K Buy
+1,700
New +$257K ﹤0.01% 10385
2022
Q2
Sell
-4,800
Closed -$778K 12869
2022
Q1
$778K Buy
4,800
+1,500
+45% +$243K ﹤0.01% 7786
2021
Q4
$625K Sell
3,300
-2,300
-41% -$443K ﹤0.01% 8550
2021
Q3
$1.13M Sell
5,600
-7,900
-59% -$1.66M ﹤0.01% 7241
2021
Q2
$2.72M Buy
13,500
+5,700
+73% +$1.06M ﹤0.01% 5243
2021
Q1
$1.37M Buy
7,800
+1,000
+15% +$181K ﹤0.01% 6909
2020
Q4
$1.15M Sell
6,800
-700
-9% -$115K ﹤0.01% 6385
2020
Q3
$1.22M Sell
7,500
-900
-11% -$146K ﹤0.01% 5646
2020
Q2
$1.37M Buy
8,400
+6,400
+320% +$973K ﹤0.01% 5212
2020
Q1
$256K Sell
2,000
-7,400
-79% -$997K ﹤0.01% 8272
2019
Q4
$1.31M Sell
9,400
-9,700
-51% -$1.27M ﹤0.01% 5017
2019
Q3
$2.25M Buy
19,100
+14,600
+324% +$1.82M ﹤0.01% 3960
2019
Q2
$583K Sell
4,500
-4,500
-50% -$555K ﹤0.01% 6958
2019
Q1
$1.16M Buy
9,000
+4,800
+114% +$606K ﹤0.01% 4758
2018
Q4
$467K Sell
4,200
-9,700
-70% -$1.17M ﹤0.01% 6157
2018
Q3
$1.9M Buy
13,900
+3,300
+31% +$429K ﹤0.01% 4099
2018
Q2
$1.27M Sell
10,600
-4,500
-30% -$530K ﹤0.01% 4850
2018
Q1
$1.82M Buy
15,100
+6,900
+84% +$866K ﹤0.01% 4097
2017
Q4
$1.02M Sell
8,200
-23,200
-74% -$2.96M ﹤0.01% 5185
2017
Q3
$4.21M Sell
31,400
-19,700
-39% -$2.57M ﹤0.01% 2735
2017
Q2
$6.42M Buy
51,100
+19,300
+61% +$2.33M ﹤0.01% 2115
2017
Q1
$3.79M Buy
31,800
+15,300
+93% +$1.79M ﹤0.01% 2680
2016
Q4
$1.77M Sell
16,500
-37,000
-69% -$4.02M ﹤0.01% 4322
2016
Q3
$6.16M Sell
53,500
-39,200
-42% -$4.47M ﹤0.01% 2005
2016
Q2
$9.5M Buy
92,700
+32,000
+53% +$3.41M 0.01% 1489
2016
Q1
$6.29M Buy
60,700
+27,900
+85% +$2.91M ﹤0.01% 2020
2015
Q4
$4.16M Buy
32,800
+11,500
+54% +$1.41M ﹤0.01% 2780
2015
Q3
$2.44M Sell
21,300
-6,100
-22% -$807K ﹤0.01% 3894
2015
Q2
$3.69M Buy
27,400
+3,900
+17% +$518K ﹤0.01% 3472
2015
Q1
$3.04M Sell
23,500
-7,000
-23% -$880K ﹤0.01% 3535
2014
Q4
$3.52M Sell
30,500
-32,000
-51% -$3.61M ﹤0.01% 3459
2014
Q3
$6.62M Buy
62,500
+3,900
+7% +$395K ﹤0.01% 2619
2014
Q2
$5.59M Buy
58,600
+11,200
+24% +$1M ﹤0.01% 2893
2014
Q1
$4.31M Sell
47,400
-24,300
-34% -$2.36M ﹤0.01% 3092
2013
Q4
$6.35M Buy
71,700
+21,000
+41% +$1.76M ﹤0.01% 2609
2013
Q3
$4.2M Buy
50,700
+34,800
+219% +$2.73M ﹤0.01% 2984
2013
Q2
$1.09M Buy
+15,900
New +$1.11M ﹤0.01% 4857

Other funds holding BBH

Susquehanna International Group's BBH Position: Q1 2026 in Review

Susquehanna International Group increased its VanEck Biotech ETF (BBH) stake by 117% in Q1 2026, buying an estimated $268K and bringing the position to 2,579 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #9756.

Susquehanna International Group first reported a position in BBH in Q2 2013 and has held it in 50 quarters since. The position peaked at $11M in Q4 2013. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Susquehanna International Group held 2,579 shares of VanEck Biotech ETF worth $485K as of Q1 2026.
  • Susquehanna International Group bought 1,391 VanEck Biotech ETF shares in Q1 2026, an estimated $268K.
  • VanEck Biotech ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9756 holding.
  • Susquehanna International Group first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 50 quarters since.
  • Susquehanna International Group's VanEck Biotech ETF position peaked at $11M in Q4 2013.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.